Arvee Laboratories (India) Limited Market Cap ($25.48 Million)
Market Cap & Net Worth: Arvee Laboratories (India) Limited (ARVEE)
Arvee Laboratories (India) Limited market cap. Arvee Laboratories (India) Limited (NSE:ARVEE) has a market capitalization of $25.48 Million (Rs2.36 Billion) as of November 4, 2026. Listed on the NSE stock exchange, this India-based company holds position #24141 globally and #1327 in its home market, demonstrating a 24.85% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Arvee Laboratories (India) Limited's stock price Rs213.80 by its total outstanding shares 11020000 (11.02 Million). Also see ARVEE cash generation efficiency for how efficiently the company converts equity into cash flow.
Arvee Laboratories (India) Limited Market Cap History (2018–2026)
Arvee Laboratories (India) Limited market cap history from 2018 to 2026. Data shows growth from $3.07 Million to $25.48 Million (24.73% CAGR). Check Arvee Laboratories (India) Limited (ARVEE) share price today for real-time trading data and today's change.
Arvee Laboratories (India) Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Arvee Laboratories (India) Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore ARVEE net asset momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.07x
Arvee Laboratories (India) Limited's market cap is 0.07 times its annual revenue
Latest Price to Earnings (P/E) Ratio
1.18x
Arvee Laboratories (India) Limited's market cap is 1.18 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2018 | $3.07 Million | $447.67 Million | $10.89 Million | 0.01x | 0.28x |
| 2019 | $3.19 Million | $539.54 Million | $22.63 Million | 0.01x | 0.14x |
| 2020 | $4.95 Million | $448.42 Million | $22.99 Million | 0.01x | 0.22x |
| 2021 | $9.92 Million | $471.44 Million | $26.77 Million | 0.02x | 0.37x |
| 2022 | $15.45 Million | $403.27 Million | $25.74 Million | 0.04x | 0.60x |
| 2023 | $20.61 Million | $612.76 Million | $41.19 Million | 0.03x | 0.50x |
| 2024 | $20.71 Million | $303.42 Million | $10.52 Million | 0.07x | 1.97x |
| 2025 | $25.42 Million | $384.87 Million | $21.47 Million | 0.07x | 1.18x |
Competitor Companies of ARVEE by Market Capitalization
Companies near Arvee Laboratories (India) Limited in the global market cap rankings as of November 4, 2026. Also see Arvee Laboratories (India) Limited asset portfolio for a full breakdown of the balance sheet.
Key companies related to Arvee Laboratories (India) Limited by market ranking:
- Linde plc Ordinary Shares (NASDAQ:LIN): Ranked #95 globally with a market cap of $215.12 Billion USD.
- AIR LIQUIDE ADR 1/5/EO 11 (F:AILA): Ranked #242 globally with a market cap of $103.86 Billion USD ( €88.84 Billion EUR).
- Air Liquide SA (PA:AI): Ranked #253 globally with a market cap of $101.06 Billion USD ( €86.44 Billion EUR).
- Sherwin-Williams Co (NYSE:SHW): Ranked #319 globally with a market cap of $84.50 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #95 | Linde plc Ordinary Shares | NASDAQ:LIN | $215.12 Billion | $511.55 |
| #242 | AIR LIQUIDE ADR 1/5/EO 11 | F:AILA | $103.86 Billion | €36.60 |
| #253 | Air Liquide SA | PA:AI | $101.06 Billion | €182.56 |
| #319 | Sherwin-Williams Co | NYSE:SHW | $84.50 Billion | $340.87 |
Market Capitalization of Arvee Laboratories (India) Limited (2018–2026)
Market capitalization of Arvee Laboratories (India) Limited from 2018 to today. Between 2018 and today, Arvee Laboratories (India) Limited's market cap moved from $3.07 Million to $ 25.48 Million, with a yearly change of 24.73%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Rs25.48 Million | +0.22% |
| 2025 | Rs25.42 Million | +22.77% |
| 2024 | Rs20.71 Million | +0.47% |
| 2023 | Rs20.61 Million | +33.40% |
| 2022 | Rs15.45 Million | +55.83% |
| 2021 | Rs9.92 Million | +100.48% |
| 2020 | Rs4.95 Million | +55.14% |
| 2019 | Rs3.19 Million | +3.88% |
| 2018 | Rs3.07 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 4th, 2026 the market cap of Arvee Laboratories (India) Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $25.48 Million USD |
| MoneyControl | $25.48 Million USD |
| MarketWatch | $25.48 Million USD |
| marketcap.company | $25.48 Million USD |
| Reuters | $25.48 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Arvee Laboratories (India) Limited
Arvee Laboratories (India) Ltd. manufactures and sells various specialized chemicals in India. The company offers polymer modifiers, including dimethyl 5-sodiosulfoisophthalate, 5-sulfoisophthalic acid mono sodium salt, 5-sulfoisophthalic acid mono lithium salt, and 5-sodiosulfo-bis-(ß-hydroxyethyl)-isophthalate; and contrast media intermediates, such as 5-nitroisophthalic acid, dimethyl 5-nitroi… Read more